SCHEMBL6627488

SCHEMBL6627488

COc1ccncc1-c1nc(-c2ccc(Cl)cc2)cs1

nearest known ligand 0.61

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 3/20 0.61
RAB9A P51151 3/20 0.61
LMNA P02545 2/20 0.61
SMN1; SMN2 Q16637 2/20 0.61
CYP19A1 P11511 5/20 0.54
RXFP1 Q9HBX9 1/20 0.52
CYP1A1 P04798 4/20 0.50
CYP1B1 Q16678 4/20 0.50
NPC1 O15118 2/20 0.49
CYP1A2 P05177 2/20 0.49
CYP3A4 P08684 2/20 0.49
MAPT P10636 1/20 0.49
NPSR1 Q6W5P4 1/20 0.49
L3MBTL1 Q9Y468 1/20 0.49
ALOX5 P09917 3/20 0.48
CYP2E1 P05181 1/20 0.46
CYP2C8 P10632 1/20 0.46
CYP2D6 P10635 1/20 0.46
CYP2A6 P11509 1/20 0.46
CYP2C9 P11712 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3814593 0.82 KDM4E (0.66) KDM4ERAB9ALMNASMN1; SMN2CYP19A1
SCHEMBL3813712 0.82 KDM4E (0.69) KDM4ERAB9ALMNASMN1; SMN2CYP19A1
SCHEMBL3815644 0.79 RAB9A (0.54) KDM4ERAB9ALMNASMN1; SMN2CYP19A1
SCHEMBL11453481 0.79 CYP1A1 (0.67) KDM4ERAB9ASMN1; SMN2RXFP1CYP1A1
SCHEMBL6647162 0.79 KDM4E (0.61) KDM4ERAB9ALMNASMN1; SMN2CYP19A1
SCHEMBL6646406 0.79 KDM4E (0.61) KDM4ERAB9ALMNASMN1; SMN2CYP19A1
SCHEMBL5049092 0.78 GSK3B (0.49) SMN1; SMN2CYP1A2NPSR1CYP2E1CYP2C8
SCHEMBL6647164 0.78 KDM4E (0.59) KDM4ERAB9ALMNASMN1; SMN2CYP19A1
SCHEMBL3824243 0.77 KDM4E (0.58) KDM4ERAB9ALMNASMN1; SMN2CYP19A1
SCHEMBL4279626 0.77 ALOX5 (0.64) KDM4ERAB9ALMNASMN1; SMN2CYP19A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1432706-A2 3-PYRIDYL OR 4-ISOQUINOLINYL THIAZOLES AS C17,20 LYASE INHIBITORS Bayer Pharmaceuticals Corporation (US) 2004-06-30 EP disclosed
WO-2003027085-A2 3-PYRIDYL OR 4-ISOQUINOLINYL THIAZOLES AS C17,20 LYASE INHIBITORS BAYER PHARMACEUTICALS CORPORATION (US) 2003-04-03 WO disclosed